Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01702987 · ClinicalTrials.gov registry record · NA
Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS
A NA study of Hypercholesterolemia and Myopathy, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT01702987 is a NA study of Hypercholesterolemia and Myopathy that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 22 participants, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01702987, a NA study of Hypercholesterolemia and Myopathy, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
It is our primary hypothesis that statin drugs impair skeletal muscle mitochondrial function and that ubiquinol (the reduced active form of CoQ10) supplementation will block impairment of PCr recovery kinetics in patients using statins. The investigators propose a pilot study to extend our research to examine PCr recovery kinetics in 20 statin users randomized in a parallel arm study to either ubiquinol or placebo over 4 weeks.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT placebo
- DIETARY_SUPPLEMENT ubiquinol
- DRUG statin
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01702987
The ClinicalTrials.gov registry entry for NCT01702987 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 816-participant average among 62 other Hypercholesterolemia trials with a reported enrollment target (97% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypercholesterolemia appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.
NCT01702987 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01702987 about?
NCT01702987 is a clinical study titled "Evaluation of Ubiquinol on Mitochondrial Oxidative Capacity in Statin Patients Using 31PMRS". It is our primary hypothesis that statin drugs impair skeletal muscle mitochondrial function and that ubiquinol (the reduced active form of CoQ10) supplementation will block impairment of PCr recovery kinetics in patients using statins. The investigators propose a pilot study to extend our research ...
What is the current status of trial NCT01702987?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2012-10. Estimated completion is 2013-10.
What conditions does trial NCT01702987 study?
This clinical trial studies the following conditions: Hypercholesterolemia, Myopathy, HMG COA Reductase Inhibitor Adverse Reaction.
What interventions are being tested in trial NCT01702987?
The interventions under investigation include: placebo (DIETARY_SUPPLEMENT), ubiquinol (DIETARY_SUPPLEMENT), statin (DRUG).
Who is sponsoring clinical trial NCT01702987?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01702987 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypercholesterolemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
RECRUITING · NA
-
Pharmacogenomic Informed Statin Prescribing
RECRUITING · NA
-
A Tool to Help Patients With Muscle Symptoms After Taking a Statin Medication.
ACTIVE NOT RECRUITING · NA
-
Effect of Diabetes Mellitus on Cholesterol Metabolism
COMPLETED · NA
-
Evaluating the Efficacy of Pediatric Lipid Screening Alerts
COMPLETED · NA
-
Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected Patients
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.